TherapeuticsMD(US:TXMD)2025-05-13 20:15Form 8-K Current Report Item 2.02 Results of Operations and Financial Condition This section reports on the company's results of operations and financial condition by incorporating information from Item 7.01 - Financial results disclosure under this item references information provided in Item 7.01 of the same Form 8-K report4 Item 7.01 Regulation FD Disclosure TherapeuticsMD issued a press release on May 13, 2025, announcing its first quarter 2025 financial results, furnished as Exhibit 99.1 - A press release announcing financial results for the quarter ended March 31, 2025, was issued on May 13, 20255 - The press release is furnished as Exhibit 99.1 and is not considered "filed" under the Securities Exchange Act of 1934, limiting liability under Section 1856 Item 9.01 Financial Statements and Exhibits This section lists the exhibits filed with the Current Report, primarily the press release containing the company's first quarter 2025 financial results Exhibit List | Exhibit No. | Description | | :--- | :--- | | 99.1 | Press Release from TherapeuticsMD, Inc., dated May 13, 2025, entitled "TherapeuticsMD Announces First Quarter 2025 Financial Results" | | 104 | Cover Page Interactive Data File (the cover page tags are embedded within the Inline XBRL document) |